Children with pulmonary arterial hypertension and prostanoid therapy: Long-term hemodynamics
- 1 May 2013
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 32 (5) , 546-552
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Add-On Therapy with Subcutaneous Treprostinil for Refractory Pediatric Pulmonary HypertensionThe Journal of Pediatrics, 2011
- Outcome of Pediatric Patients With Pulmonary Arterial Hypertension in the Era of New Medical TherapiesThe American Journal of Cardiology, 2010
- Effectiveness of Transition from Intravenous Epoprostenol to Oral/Inhaled Targeted Pulmonary Arterial Hypertension Therapy in Pediatric Idiopathic and Familial Pulmonary Arterial HypertensionThe American Journal of Cardiology, 2010
- Effects of Long-Term Sildenafil Treatment for Pulmonary Hypertension in Infants with Chronic Lung DiseaseThe Journal of Pediatrics, 2009
- Short- and Long-Term Effects of Inhaled Iloprost Therapy in Children With Pulmonary Arterial HypertensionJACC, 2008
- Epoprostenol treatment in children with severe pulmonary hypertensionHeart, 2007
- Effects of Long-Term Bosentan in Children With Pulmonary Arterial HypertensionJACC, 2005
- Survival in Primary Pulmonary HypertensionCirculation, 2002
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.Circulation, 1982